Ad
ABT Stock - Abbott Laboratories Stock Trading
About | Abbott Laboratories (NYSE:ABT)
Not available
Quote | Abbott Laboratories (NYSE:ABT)
| Last: | $115.515 |
|---|---|
| Change Percent: | 1.45% |
| Open: | $114.46 |
| Close: | $113.86 |
| High: | $115.72 |
| Low: | $114.32 |
| Volume: | 332,707 |
| Last Trade Date Time: | 09/09/2024 03:00:00 am |
News | Abbott Laboratories (NYSE:ABT)
-
2024-09-06 15:45:48 ET More on Applied DNA Sciences Mpox Stocks Have Popped, But Pickings Are Slim For The Discerning Investor Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript Singapore announces quarantine measures for close contacts of mpox infect...
-
2024-09-05 13:36:19 ET More on United States 2-Year Bond Yield: Market And Economic Insights From August 2024 What The Short-Term Treasury Market Says About Rate Cuts, And How Wrong It Was So Far Week Ahead: Politics, Economics, And The Yen Nasdaq wavers, S&a...
Message Board Posts | Abbott Laboratories (NYSE:ABT)
| Subject | By | Source | When |
|---|---|---|---|
| $ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
| $ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
| $ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
| whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
| FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S. PR Newswire Designed for people interested in improving their overall health and wellness Provides real-time glucose data and personal coaching insights based on the body's ...
-
Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression PR Newswire The U.S. FDA granted Abbott Breakthrough Device designation to explore deep brain stimulation (DBS) for treatment-resistant depression (TRD) as an o...
-
2024-08-31 21:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...